Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial

Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-02T01:52:29.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed descriptions of a Phase III study on benralizumab for hypereosinophilic syndrome, while adding a new registry identifier and a masking description. The revision number has also been updated.
    Difference
    48%
    Check dated 2025-04-16T14:44:00.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 13, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.2%
    Check dated 2025-04-09T09:52:35.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version release, moving from v2.14.2 to v2.14.3, and the last update date has changed from February 13, 2025, to March 25, 2025.
    Difference
    0.2%
    Check dated 2025-04-01T23:32:39.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T20:50:47.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The study has transitioned from a recruiting status to an active status, indicating that patient recruitment has concluded. Additionally, the study's timeline has been updated with new dates for the primary database lock and the open-label extension period.
    Difference
    46%
    Check dated 2025-02-17T14:56:47.000Z thumbnail image

Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.